1 study found for:    12563018 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Safety Study of IPI-504 in Patients With Relapsed and Relapsed Refractory Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: IPI-504

Indicates status has not been verified in more than two years